Here are three points:
1. The investment management firm now holds a total of 1.5 million NuVasive shares, valued at $79.7 million.
2. NuVasive reported total revenue of $215.1 million in first quarter of 2016, an 11.8 percent increase from the $192.4 million reported for the first quarter of 2015.
3. The company’s net loss reached $8.9 million for the first quarter 2016.
More articles on devices:
33 organizations implore Congress to postpone CMS equipment proposal: 5 things to know
Simplifying orthopedics in a complex industry — Dr. Joe Kohli changes the game with [m]pirik
InVivo Therapeutics shares mission on radio broadcast — 3 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
